No takes yet. Share an insight, caveat, or question.
Experimental study demonstrates size-dependent antibacterial potency of saccharide-synthesized silver nanoparticles against drug-resistant bacteria, suggesting scalable antimicrobial utility.
Panáček et al. (2006) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: